The University City Science Center, a research park in Philadelphia, has announced the six startups that will be part of the second class for its health tech accelerator, called Digital Health Accelerator.
The program will run for a year. When the accelerator is finished, startups receive up to $50,000. The Center adds that startups in the program will also get to network with insurance companies, pharmaceutical companies, hospitals, and research institutions. Startups also receive coworking office space during the program.
Correction: A previous version of this article incorrectly stated that the accelerator's first class ran for less than a year.
DHA shares their building with another accelerator, DreamIt Health. Last year’s DHA program accepted seven startups, including Biomeme and Fitly, who had both previously been through DreamIt Health. Since graduating from DHA, the first class of startups raised almost $9 million in funding and generated more than $1 million in revenue.
This year, DHA received funding from the US Small Business Administration Growth Accelerator Fund so that the accelerator could focus on minority- and women-led startups as well as from the Commonwealth of Pennsylvania’s Department of Community and Economic Development.
In the last few weeks, two other health tech accelerators were announced. Nashville-based Entrepreneur Center announced the launch of an accelerator called Project Healthcare and Merck announced that it will launch a digital accelerator program in Kenya that is equity free.
Here are the six startups in DHA’s second class:
Grand Round Table emails primary care providers a daily summary of their scheduled patient follow-ups so providers can better manage high-risk patients.
Graphwear Technologies has developed a graphene patch which measures dehydration, glucose, and lactic acid levels, from sweat.
InvisAlert Solutions aims to improve compliance by using a wearable device to help care providers monitor patients in healthcare organizations.
Oncora Medical aims to reduce toxic radiation side effect in patients using a tool for planning personalized cancer radiotherapy.
One Health Company enrolls ill pets in trials of cutting-edge therapies to improve the wellness of their pets and help develop new therapies for human medicine.